These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10850864)

  • 1. A qualitative and quantitative study of grumose degeneration in progressive supranuclear palsy.
    Ishizawa K; Lin WL; Tiseo P; Honer WG; Davies P; Dickson DW
    J Neuropathol Exp Neurol; 2000 Jun; 59(6):513-24. PubMed ID: 10850864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process.
    Togo T; Dickson DW
    Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter pathology in progressive supranuclear palsy (PSP): a quantitative study of 8 cases.
    Armstrong RA
    Clin Neuropathol; 2013; 32(5):399-405. PubMed ID: 23587170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning-based decision tree classifier for the diagnosis of progressive supranuclear palsy and corticobasal degeneration.
    Koga S; Zhou X; Dickson DW
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):931-941. PubMed ID: 33763863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferior olivary hypertrophy is uncommon in progressive supranuclear palsy.
    Katsuse O; Dickson DW
    Acta Neuropathol; 2004 Aug; 108(2):143-6. PubMed ID: 15235807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistological study of grumose degeneration of the dentate nucleus in progressive supranuclear palsy.
    Cruz-Sanchez FF; Rossi ML; Cardozo A; Picardo A; Tolosa E
    J Neurol Sci; 1992 Jul; 110(1-2):228-31. PubMed ID: 1324296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical progressive supranuclear palsy with corticospinal tract degeneration.
    Josephs KA; Katsuse O; Beccano-Kelly DA; Lin WL; Uitti RJ; Fujino Y; Boeve BF; Hutton ML; Baker MC; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):396-405. PubMed ID: 16691120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unexpected abundance of pathological tau in progressive supranuclear palsy white matter.
    Zhukareva V; Joyce S; Schuck T; Van Deerlin V; Hurtig H; Albin R; Gilman S; Chin S; Miller B; Trojanowski JQ; Lee VM
    Ann Neurol; 2006 Sep; 60(3):335-45. PubMed ID: 16823854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive supranuclear palsy: Neuropathology of patients with a short disease duration due to unexpected death.
    Zhang L; Toyoshima Y; Takeshima A; Shimizu H; Tomita I; Onodera O; Takahashi H; Kakita A
    Neuropathology; 2021 Jun; 41(3):174-182. PubMed ID: 33205528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrophy of superior cerebellar peduncle in progressive supranuclear palsy.
    Tsuboi Y; Slowinski J; Josephs KA; Honer WG; Wszolek ZK; Dickson DW
    Neurology; 2003 Jun; 60(11):1766-9. PubMed ID: 12796528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive supranuclear palsy and corticobasal degeneration: lumping versus splitting.
    Scaravilli T; Tolosa E; Ferrer I
    Mov Disord; 2005 Aug; 20 Suppl 12():S21-8. PubMed ID: 16092076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradient subthalamic neurodegeneration and tau pathology in the hypoglossal nucleus as essential pathological markers of progressive supranuclear palsy - Richardson syndrome.
    Homma T; Mochizuki Y; Hara M; Kamei S; Mizutani T; Takubo H; Isozaki E; Takahashi M; Komori T; Hao H
    Rev Neurol (Paris); 2020 May; 176(5):353-360. PubMed ID: 32247606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of atypical progressive supranuclear palsy with degeneration of the fronto-pontine tracts, and without grumose degeneration of the dentate nucleus].
    Inagaki T; Ishino H; Iijima M; Seno H; Kikumoto O; Yoshinaga J; Matsuura H; Tachiyama Y
    No To Shinkei; 1996 Nov; 48(11):1037-45. PubMed ID: 8951896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spatial patterns of the tau pathology in progressive supranuclear palsy.
    Armstrong RA; Cairns NJ
    Neurol Sci; 2013 Mar; 34(3):337-44. PubMed ID: 22411688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mossy fiber involvement in progressive supranuclear palsy.
    Arai K; Braak E; de Vos RA; Jansen Steur EN; Braak H
    Acta Neuropathol; 1999 Oct; 98(4):341-4. PubMed ID: 10502037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial activation parallels system degeneration in progressive supranuclear palsy and corticobasal degeneration.
    Ishizawa K; Dickson DW
    J Neuropathol Exp Neurol; 2001 Jun; 60(6):647-57. PubMed ID: 11398841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy: pathology and genetics.
    Dickson DW; Rademakers R; Hutton ML
    Brain Pathol; 2007 Jan; 17(1):74-82. PubMed ID: 17493041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.